Clinical Trials in Phoenix

Showing 2161-2180 of 7,960 trials

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

NCT04239625

The purpose of this open-label, multicenter study is to determine the long-term safety, pharmacokinetics and effects of ALK-001 (C20-D3-retinyl acetate) on the progression of Stargardt disease. This study is an extension of NCT02402660 and enrolls participants who are at least 8 years old. Enrollment is by invitation only. Funding Source - FDA OOPD

Stargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy+1 more

Alkeus Pharmaceuticals, Inc.200 participantsStarted Dec 2019

Phoenix, Arizona, United States • Los Angeles, California, United States • Aurora, Colorado, United States +5 more locations

COMPLETED< 1 mile

Burn Validation Study

NCT06131203

The purpose of this study is to validate the algorithm for burn healing assessment by the Spectral MD DeepView device which would provide burn healing potential assessment.

BurnsWound HealWounds and Injuries

SpectralMD274 participantsStarted Dec 2023

Phoenix, Arizona, United States • Sacramento, California, United States • Sacramento, California, United States +18 more locations

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

Burn Validation Study

Find Trials by Condition in Phoenix

HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis

DALY II USA/ MB-CART2019.1 for DLBCL

Back to ECE Safely With SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers

Treatment of Persistent Atrial Fibrillation With Sphere-9 Catheter and Affera Mapping and Ablation System

MTT for Children With ASD Who Have Gastrointestinal Disorders

A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases

A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA

A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

Study of REM-422 in Patients With AML or Higher Risk MDS

Assessment of a Non-invasive Device in the Management of Open Abdomen (AbCLO)

Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula

User Acceptability Evaluation of Pseudophakic Patients Previously Implanted With the TECNIS Odyssey IOL

A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

Safety and Efficacy of GS-100 Gene Therapy in Patients With NGLY1 Deficiency